Hematology: Clinical Studies Open For Enrollment
Allogeneic Stem Cell Transplant to Induce Mixed Donor Chimerism in Patients with Sickle Cell Disease & Thalassemia NYMC 556
Eligibility
- Subject is 30 years of age or younger
- Diagnosis of Homozygous Hemoglobin S Disease or Heterozygous Hemoglobin Sickle Cell (SC) or S 0/+ thalassemia, or Sickle/variant resulting in Chronic Hemolytic Anemia with hemoglobin (HgB) less than or equal to 10 mg/dL
Enrollment Status: Enrolling
Study Information
ClinicalTrials.gov | NCT00408447
Principal Investigator
Mitchell S. Cairo, MD
Contact for Study Screening
Lauren_Harrison@nymc.edu
Analysis of Patients Treated for Chronic Granulomatous Disease
Enrollment Status: Enrolling
Principal Investigator
Jordan Brittni Milner, MD
Contact for Study Screening
Lauren_Harrison@nymc.edu
A prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children with SCID Disorders
Enrollment Status: Enrolling
Principal Investigator
Jordan Brittni Milner, MD
Contact for Study Screening
Lauren_Harrison@nymc.edu
The use of dose dense rituximab for high risk patients with newly diagnosed acute immune thrombocytopenic purpura
Enrollment Status: Enrolling
Principal Investigator
Jordan Brittni Milner, MD
Contact for Study Screening
Lauren_Harrison@nymc.edu
A Pilot Study to Determine the Safety of Defibrotide in Children with High Risk Kawasaki Disease (NYMC-204)
Eligibility
- Subject is 11 years of age or younger
- Kawasaki disease presumptive diagnosis and initiation of defibrotide within 96 hours from the conclusion of IVIG treatment
Enrollment Status: Enrolling
Study Information
ClinicalTrials.gov | NCT04777422
Principal Investigator
Mitchell S. Cairo, MD
Contact for Study Screening
Lauren_Harrison@nymc.edu